Breaking News Instant updates and real-time market news.

2020-05-28 08:36:08 HXL Hexcel $36.59 / +2.005 (+5.80%) , BA Boeing $149.46 / +4.77 (+3.30%) 08:36 05/28/20 05/28 08:36 05/28/20 08:36	Hexcel price target raised to $45 from $37 at BMO Capital BMO Capital analyst John McNulty raised the firm's price target on Hexcel (HXL) to $45 from $37 but keeps a Market Perform rating on the shares. The stock should be up "solidly" on the news that Boeing (BA) is resuming its production of the 737 MAX program, the analyst tells investors in a research note, and while the ramp-up in output should be slow, the restart implies that the planemaker is gaining confidence in their ability to get FAA approval for the platform. The difficult Aerospace backdrop keeps McNulty at neutral, though the analyst also believes that Hexcel offers one of the better liquidity positions in the space. HXL Hexcel $36.59 / +2.005 (+5.80%) BA Boeing $149.46 / +4.77 (+3.30%)	01 Jun
HXL BA HXL Hexcel $36.59 / +2.005 (+5.80%) 05/22/20 Alembic Global Hexcel initiated with a Neutral at Alembic Global 05/22/20 Alembic Global Hexcel initiated with a Neutral at Alembic Global 04/27/20 Loop Capital Hexcel price target lowered to $33 from $50 at Loop Capital 04/23/20 BMO Capital Hexcel price target lowered to $37 from $45 at BMO Capital BA Boeing $149.46 / +4.77 (+3.30%) 05/22/20 Canaccord Boeing price target lowered to $155 from $175 at Canaccord 05/20/20 RBC Capital RBC starts Boeing at Outperform on favorable risk/reward profile 05/20/20 RBC Capital Boeing initiated with an Outperform at RBC Capital 05/05/20 Nord/LB Boeing downgraded to Sell from Hold at Nord/LB

2020-05-28 08:36:08

HXL

Hexcel

$36.59 / +2.005 (+5.80%)

, BA

Boeing

$149.46 / +4.77 (+3.30%)

08:36

05/28/20

05/28

08:36

05/28/20

08:36

Hexcel price target raised to $45 from $37 at BMO Capital

BMO Capital analyst John McNulty raised the firm's price target on Hexcel (HXL) to $45 from $37 but keeps a Market Perform rating on the shares. The stock should be up "solidly" on the news that Boeing (BA) is resuming its production of the 737 MAX program, the analyst tells investors in a research note, and while the ramp-up in output should be slow, the restart implies that the planemaker is gaining confidence in their ability to get FAA approval for the platform. The difficult Aerospace backdrop keeps McNulty at neutral, though the analyst also believes that Hexcel offers one of the better liquidity positions in the space.

HXL

Hexcel

$36.59 / +2.005 (+5.80%)

Boeing

$149.46 / +4.77 (+3.30%)

01
Jun

HXL Hexcel

$36.59 / +2.005 (+5.80%)

05/22/20 Alembic Global: Hexcel initiated with a Neutral at Alembic Global

05/22/20 Alembic Global: Hexcel initiated with a Neutral at Alembic Global

04/27/20 Loop Capital: Hexcel price target lowered to $33 from $50 at Loop Capital

04/23/20 BMO Capital: Hexcel price target lowered to $37 from $45 at BMO Capital

BA Boeing

$149.46 / +4.77 (+3.30%)

05/22/20 Canaccord: Boeing price target lowered to $155 from $175 at Canaccord

05/20/20 RBC Capital: RBC starts Boeing at Outperform on favorable risk/reward profile

05/20/20 RBC Capital: Boeing initiated with an Outperform at RBC Capital

05/05/20 Nord/LB: Boeing downgraded to Sell from Hold at Nord/LB

TODAY'S FREE FLY STORIES

Upgrade	Nordic Entertainment upgraded to Buy from Hold at Nordea » 05:19 01/21/21 01/21 05:19 01/21/21 05:19 NENTF Nordic Entertainment $0.00 / + (+0.00%) Nordea analyst Klas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research NENTF Nordic Entertainment $0.00 / + (+0.00%) 12/04/20 Morgan Stanley Nordic Entertainment upgraded to Overweight from Equal Weight at Morgan Stanley 11/18/20 Berenberg Nordic Entertainment initiated with a Buy at Berenberg 05/18/20 Morgan Stanley Nordic Entertainment price target lowered to SEK 230 at Morgan Stanley
Downgrade	Fluidra downgraded to Hold from Buy at Santander » 05:18 01/21/21 01/21 05:18 01/21/21 05:18 FLUIF Fluidra $0.00 / + (+0.00%) Santander analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FLUIF Fluidra $0.00 / + (+0.00%) 01/08/21 Berenberg Fluidra price target raised to EUR 22 from EUR 18 at Berenberg 12/03/20 HSBC Fluidra downgraded to Hold from Buy at HSBC 10/30/20 Berenberg Fluidra price target raised to EUR 18 from EUR 17.50 at Berenberg 10/29/20 JPMorgan Fluidra price target raised to EUR 17 from EUR 16 at JPMorgan
Upgrade	Ternium upgraded to Outperform from Neutral at Bradesco BBI » 05:17 01/21/21 01/21 05:17 01/21/21 05:17 TX Ternium $30.26 / -0.06 (-0.20%) Bradesco BBI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TX Ternium $30.26 / -0.06 (-0.20%) 10/13/20 Ternium falls -11.5% TX Ternium $30.26 / -0.06 (-0.20%) 11/24/20 UBS Ternium upgraded to Neutral from Sell at UBS 11/06/20 Fly Intel: Top five analyst upgrades 11/06/20 JPMorgan Ternium upgraded to Overweight on steel recovery at JPMorgan 11/06/20 JPMorgan Ternium upgraded to Overweight from Neutral at JPMorgan TX Ternium $30.26 / -0.06 (-0.20%) 11/03/20 Ternium sees Q4 EBITDA up from Q3 11/03/20 Ternium reports Q3 EPS 74c, consensus 26c TX Ternium $30.26 / -0.06 (-0.20%) 11/03/20 Fly Intel: After-Hours Movers
Upgrade	Usiminas upgraded to Outperform from Neutral at Bradesco BBI » 05:17 01/21/21 01/21 05:17 01/21/21 05:17 USNZY Usiminas $0.00 / + (+0.00%) Bradesco BBI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research USNZY Usiminas $0.00 / + (+0.00%) 09/17/20 Credit Suisse Usiminas upgraded to Neutral from Underperform at Credit Suisse 09/02/20 JPMorgan Usiminas upgraded to Overweight from Neutral at JPMorgan 07/24/20 Itau BBA Usiminas upgraded to Outperform from Market Perform at Itau BBA 06/19/20 Bradesco BBI Usiminas upgraded to Neutral from Underperform at Bradesco BBI
Upgrade	Skandinaviska Enskilda upgraded to Hold from Reduce at Kepler Cheuvreux » 05:16 01/21/21 01/21 05:16 01/21/21 05:16 SVKEF Skandinaviska Enskilda $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SVKEF Skandinaviska Enskilda $0.00 / + (+0.00%) 01/11/21 UBS Skandinaviska Enskilda price target raised to SEK 91 from SEK 85 at UBS 01/07/21 Credit Suisse Skandinaviska Enskilda downgraded to Underperform from Neutral at Credit Suisse 01/07/21 Credit Suisse Skandinaviska Enskilda downgraded to Underperform from Neutral at Credit Suisse 11/19/20 AlphaValue Skandinaviska Enskilda upgraded to Reduce from Sell at AlphaValue

Downgrade	Pearson downgraded to Neutral from Outperform at Exane BNP Paribas » 05:14 01/21/21 01/21 05:14 01/21/21 05:14 PSO Pearson $10.04 / +0.79 (+8.54%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PSO Pearson $10.04 / +0.79 (+8.54%) 12/02/20 Pearson announces Mike Howells as new Chief Strategy Officer 10/14/20 Pearson 'on track' to deliver 2020 outturn in line with expectations 08/24/20 Pearson names Disney executive Andy Bird as new CEO, effective October 19 PSO Pearson $10.04 / +0.79 (+8.54%) 01/12/21 Berenberg Pearson price target raised to 475 GBp from 450 GBp at Berenberg 12/17/20 UBS Pearson price target raised to 750 GBp from 650 GBp at UBS 12/09/20 Fly Intel: Top five analyst downgrades 12/09/20 Kepler Cheuvreux Pearson cut to Reduce at Kepler Cheuvreux after recent share price rally PSO Pearson $10.04 / +0.79 (+8.54%) 10/14/20 Pearson reports Q3 revenue down 10% y/y vs. down 28% in Q2 07/24/20 Pearson reports 1H EPS 6.3p versus 6.1p in 1H19
Hot Stocks	Silvercorp Metals to acquire exploration rights to Zhonghe Project for $76M » 05:13 01/21/21 01/21 05:13 01/21/21 05:13 SVM Silvercorp Metals $6.14 / +0.33 (+5.68%) Silvercorp Metals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options SVM Silvercorp Metals $6.14 / +0.33 (+5.68%) 01/15/21 Silvercorp Metals reports production of ~900 ounces of gold in Q3 08/31/20 Silvercorp reports 18% increase in measured and indicated silver resources 07/28/20 Avalon Investment Holdings announce $4.5M investment of Silvercorp Metals SVM Silvercorp Metals $6.14 / +0.33 (+5.68%) 09/14/20 Canaccord Silvercorp Metals initiated with a Hold at Canaccord 09/01/20 BMO Capital Silvercorp Metals price target raised to C$10.50 from C$8.25 at BMO Capital 08/28/20 PI Financial Silvercorp Metals price target raised to C$10 from C$9 at PI Financial 08/10/20 BMO Capital Silvercorp Metals price target raised to C$8.25 from C$6.75 at BMO Capital SVM Silvercorp Metals $6.14 / +0.33 (+5.68%) 11/16/20 Sixteen new option listings and one option delisting on November 16th
Upgrade	ASML upgraded to Buy from Neutral at New Street » 05:13 01/21/21 01/21 05:13 01/21/21 05:13 ASML ASML $549.78 / +0.02 (+0.00%) New Street Research… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Periodicals Events ASML ASML $549.78 / +0.02 (+0.00%) 01/19/21 Barclays ASML price target raised to EUR 525 from EUR 475 at Barclays 01/15/21 JPMorgan ASML price target raised to EUR 437 from EUR 408 at JPMorgan 01/14/21 Barclays ASML price target raised to EUR 475 from EUR 425 at Barclays 01/13/21 UBS ASML price target raised to EUR 430 from EUR 395 at UBS ASML ASML $549.78 / +0.02 (+0.00%) 01/20/21 ASML sees Q1 net sales EUR 3.9B-EUR 4.1B, gross margin 50%-51% 01/20/21 ASML reports Q4 EPS EUR 3.23 vs. EUR 2.54 last quarter 10/14/20 ASML sees Q4 revenue EUR3.6B-EUR3.8B 10/14/20 ASML reports Q3 EPS EUR2.54 vs. EUR1.79 last quarter ASML ASML $549.78 / +0.02 (+0.00%) 11/13/20 TSMC places EUV equipment orders with ASML for 2021, DigiTimes reports 02/11/21 Technology & Internet Virtual Conference 01/26/21 ASML 01/27/21 ASML
Downgrade	Corteva downgraded to Neutral from Buy at Redburn » 05:12 01/21/21 01/21 05:12 01/21/21 05:12 CTVA Corteva $43.67 / +0.15 (+0.34%) Redburn analyst Tony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events CTVA Corteva $43.67 / +0.15 (+0.34%) 01/19/21 Matrix Service subsidiary awarded construction of water facility by Corteva 01/04/21 Corteva welcomes new Chief Technology Officer Sam Eathington 12/23/20 Tyson Foods appoints Megan Britt as VP, investor relations 11/13/20 Starboard Value takes Corteva stake, exits eBay CTVA Corteva $43.67 / +0.15 (+0.34%) 01/19/21 Deutsche Bank Corteva named 'Catalyst Call: Buy Idea' at Deutsche Bank 01/08/21 Deutsche Bank Corteva price target raised to $50 from $40 at Deutsche Bank 12/18/20 Susquehanna Corteva downgraded to Neutral from Positive at Susquehanna 12/14/20 Morgan Stanley Morgan Stanley upgrades Corteva, points to five reasons for above-consensus view CTVA Corteva $43.67 / +0.15 (+0.34%) 11/04/20 Corteva backs FY20 operating EPS view $1.25-$1.45, consensus $1.38 11/04/20 Corteva reports Q3 adjusted EPS (39c), consensus (42c) 11/04/20 Notable companies reporting after market close 08/05/20 Corteva sees FY20 operating EPS $1.25-$1.45, consensus $1.40 CTVA Corteva $43.67 / +0.15 (+0.34%) 11/19/20 Corteva board backs CEO amid pressure from Starboard, Reuters says 10/09/20 Starboard makes new bets on Corteva, ON Semiconductor, Reuters reports 02/04/21 Corteva - CTVA
Upgrade	BillerudKorsnas upgraded to Buy from Hold at Pareto » 05:12 01/21/21 01/21 05:12 01/21/21 05:12 BLRDF BillerudKorsnas $0.00 / + (+0.00%) Pareto analyst Axel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BLRDF BillerudKorsnas $0.00 / + (+0.00%) 06/23/20 Jefferies BillerudKorsnas downgraded to Underperform from Hold at Jefferies 05/28/20 Citi BillerudKorsnas downgraded to Neutral from Buy at Citi 04/27/20 Kepler Cheuvreux BillerudKorsnas upgraded to Buy from Hold at Kepler Cheuvreux

Upgrade	Sun Life Financial upgraded to Buy from Hold at Canaccord » 05:11 01/21/21 01/21 05:11 01/21/21 05:11 SLF Sun Life Financial $48.73 / +0.63 (+1.31%) Canaccord Genuity analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SLF Sun Life Financial $48.73 / +0.63 (+1.31%) 01/05/21 Obatan makes unsolicited "mini-tender offer" to Sun Life Financial 12/02/20 Sun Life Financial CEO Dean Connor to retire in 2021, Kevin Strain to succeed 11/18/20 Sun Life Financial unit, ACB form bancassurance partnership in Vietnam 10/21/20 Sun Life Financial to acquire majority stake in Crescent Capital for $338M SLF Sun Life Financial $48.73 / +0.63 (+1.31%) 01/18/21 National Bank Sun Life Financial upgraded to Outperform from Sector Perform at National Bank 01/14/21 RBC Capital Sun Life Financial downgraded to Sector Perform at RBC Capital on valuation 01/14/21 RBC Capital Sun Life Financial downgraded to Sector Perform from Outperform at RBC Capital 11/06/20 Canaccord Sun Life Financial price target raised to C$61 from C$58.50 at Canaccord SLF Sun Life Financial $48.73 / +0.63 (+1.31%) 11/04/20 Sun Life Financial reports Q3 underlying EPS C$1.44 vs. C$1.37 a year ago 02/11/21 Sun Life Financial - SLF
Downgrade	La Francaise des Jeux downgraded to Hold from Buy at Kepler Cheuvreux » 05:10 01/21/21 01/21 05:10 01/21/21 05:10 LFDJF La Francaise des Jeux $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research LFDJF La Francaise des Jeux $0.00 / + (+0.00%) 07/30/20 Kepler Cheuvreux La Francaise des Jeux upgraded to Buy from Hold at Kepler Cheuvreux 07/30/20 Kepler Cheuvreux La Francaise des Jeux upgraded to Buy from Hold at Kepler Cheuvreux
Upgrade	Adva Optical upgraded to Buy from Hold at Kepler Cheuvreux » 05:09 01/21/21 01/21 05:09 01/21/21 05:09 ADVOF Adva Optical $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ADVOF Adva Optical $0.00 / + (+0.00%) 07/20/20 Commerzbank Adva Optical upgraded to Hold from Reduce at Commerzbank
Downgrade	Triumph Group downgraded to Neutral from Outperform at Credit Suisse » 05:09 01/21/21 01/21 05:09 01/21/21 05:09 TGI Triumph Group $13.05 / -0.04 (-0.31%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TGI Triumph Group $13.05 / -0.04 (-0.31%) 11/18/20 Triumph Group extends CEO Daniel Crowley's contract, elects to Board Chair 10/14/20 Triumph Group receives extended contract for Boeing ground support operations 10/07/20 Triumph Group signs pact to provide high-speed gearboxes for Lockheed C-5 Galaxy 10/01/20 Triumph Group rises 12.0% TGI Triumph Group $13.05 / -0.04 (-0.31%) 01/11/21 Truist Triumph Group upgraded to Buy from Hold at Truist 01/11/21 Truist Triumph Group upgraded to Buy from Hold at Truist 12/01/20 Truist Triumph Group upgraded to Hold from Sell at Truist 12/01/20 Truist Triumph Group upgraded to Hold from Sell at Truist TGI Triumph Group $13.05 / -0.04 (-0.31%) 11/05/20 Triumph Group continues to see FY21 revenue $1.8B-$1.9B, consensus $1.85B 11/05/20 Triumph Group reports Q2 EPS (64c), consensus (29c) 08/04/20 Triumph Group sees FY21 revenue $1.8B-$1.9B, consensus $1.97B 08/04/20 Triumph Group reports Q2 EPS (19c), consensus (22c) TGI Triumph Group $13.05 / -0.04 (-0.31%) 09/18/20 Sector advisors think Triumph Group may attract suitors, Dealreporter says TGI Triumph Group $13.05 / -0.04 (-0.31%) 09/18/20 Fly Intel: Wall Street's top stories for Friday 09/18/20 Fly Intel: Wall Street's top stories at midday 02/03/21 Triumph Group - TGI
Downgrade	Hexcel downgraded to Underperform from Neutral at Credit Suisse » 05:08 01/21/21 01/21 05:08 01/21/21 05:08 HXL Hexcel $50.70 / +1.16 (+2.34%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events HXL Hexcel $50.70 / +1.16 (+2.34%) 11/11/20 Hexcel off highs after Solvay shoots down takeover report 11/11/20 Hexcel halted for volatility after blog report claims takeover approach made 10/20/20 Hexcel falls -6.8% 10/19/20 Hexcel falls over 6% after Q3 earnings miss HXL Hexcel $50.70 / +1.16 (+2.34%) 12/15/20 KeyBanc Hexcel downgraded to Sector Weight at KeyBanc 12/14/20 KeyBanc Hexcel downgraded to Sector Weight from Overweight at KeyBanc 12/04/20 Barclays Hexcel downgraded to Underweight from Equal Weight at Barclays 11/11/20 JPMorgan Solvay 'categorically denies' approach made to Hexcel, says JPMorgan HXL Hexcel $50.70 / +1.16 (+2.34%) 10/19/20 Hexcel reports Q3 EPS (29c), consensus 8c 07/27/20 Hexcel reports Q2 adjusted EPS 8c, consensus 20c HXL Hexcel $50.70 / +1.16 (+2.34%) 11/11/20 Hexcel tells Bloomberg not in merger talks with any party 11/11/20 Hexcel tells Bloomberg not in takeover talks with Solvay, any other party 11/11/20 Solvay tells Bloomberg not in talks to buy Hexcel, hasn't made offer HXL Hexcel $50.70 / +1.16 (+2.34%) 10/19/20 Fly Intel: After-Hours Movers 07/27/20 Fly Intel: After-Hours Movers 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 01/26/21 Hexcel - HXL

Upgrade	Spirit AeroSystems upgraded to Outperform from Neutral at Credit Suisse » 05:08 01/21/21 01/21 05:08 01/21/21 05:08 SPR Spirit AeroSystems $39.81 / +0.05 (+0.13%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SPR Spirit AeroSystems $39.81 / +0.05 (+0.13%) 11/16/20 Paul Singer's Elliott buys Cubic, exits AT&T in Q3 10/30/20 Bombardier confirms closing of aerostructures business sale 10/26/20 Bombardier announces amended terms for aerostructures sale to Spirit 10/26/20 Spirit AeroSystems and Bombardier amend purchase agreement SPR Spirit AeroSystems $39.81 / +0.05 (+0.13%) 01/11/21 Baird Baird bullish on aerospace stocks, upgrades Spirit AeroSystems 01/11/21 Baird Spirit AeroSystems upgraded to Outperform from Neutral at Baird 12/15/20 JPMorgan Spirit AeroSystems price target raised to $45 from $36 at JPMorgan 12/15/20 JPMorgan Boeing price target raised to $265 from $190 at JPMorgan SPR Spirit AeroSystems $39.81 / +0.05 (+0.13%) 11/03/20 Spirit AeroSystems reports Q3 adjusted EPS ($1.34), consensus ($1.34) 11/02/20 Notable companies reporting before tomorrow's open 11/02/20 Notable companies reporting before tomorrow's open 08/04/20 Spirit AeroSystems reports Q2 adjusted EPS ($2.28), consensus ($1.33) SPR Spirit AeroSystems $39.81 / +0.05 (+0.13%) 11/18/20 Boeing rises after FAA lifts order grounding 737 MAX 11/03/20 Fly Intel: Pre-market Movers 08/04/20 Fly Intel: Pre-market Movers SPR Spirit AeroSystems $39.81 / +0.05 (+0.13%) 10/16/20 Spirit AeroSystems call volume above normal and directionally bullish 08/11/20 Spirit AeroSystems call volume above normal and directionally bullish
Recommendations	Texas Instruments price target raised to $185 from $180 at Oppenheimer » 05:07 01/21/21 01/21 05:07 01/21/21 05:07 TXN Texas Instruments $173.37 / -0.79 (-0.45%) Oppenheimer analyst Rick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TXN Texas Instruments $173.37 / -0.79 (-0.45%) 12/09/20 Texas Instruments: Most of HiRel semiconductor products now available online 11/18/20 Xilinx works with Texas Instruments to develop DFE radio application solutions 10/20/20 Texas Instruments CEO says notable strength from rebound of automotive demand 09/21/20 Amazon Sidewalk working with Semtech, Silicon Labs and TI on new IoT chipsets TXN Texas Instruments $173.37 / -0.79 (-0.45%) 12/17/20 Deutsche Bank Texas Instruments price target raised to $150 from $145 at Deutsche Bank 12/16/20 Citi Citi sees 'substantial upside' to semi estimates after latest checks 12/14/20 Goldman Sachs Texas Instruments price target raised to $171 from $162 at Goldman Sachs 10/30/20 Citi Arrow Electronics price target raised to $85 from $75 at Citi TXN Texas Instruments $173.37 / -0.79 (-0.45%) 10/20/20 Texas Instruments sees Q4 EPS $1.20-$1.40, consensus $1.19 10/20/20 Texas Instruments reports Q3 EPS $1.45, consensus $1.27 10/20/20 Notable companies reporting after market close 07/21/20 Texas Instruments sees Q3 EPS $1.14-$1.34, consensus 99c TXN Texas Instruments $173.37 / -0.79 (-0.45%) 09/03/20 China plans domestic semiconductor overhaul in Trump retaliation, Bloomberg says 08/22/20 'Underappreciated' Synaptics shares have more upside, Barron's says 08/13/20 Intel unveils transistor technology to boost chip performance, Reuters says TXN Texas Instruments $173.37 / -0.79 (-0.45%) 10/20/20 Fly Intel: After-Hours Movers 01/26/21 Texas Instruments - TXN TXN Texas Instruments $173.37 / -0.79 (-0.45%) 12/28/20 Texas Instruments put volume heavy and directionally bearish 12/21/20 Texas Instruments put volume heavy and directionally bearish 11/10/20 Texas Instruments put volume heavy and directionally bearish 10/30/20 Texas Instruments put volume heavy and directionally bearish
Earnings	Signature Bank reports Q4 EPS $3.26, consensus $2.89 » 05:07 01/21/21 01/21 05:07 01/21/21 05:07 SBNY Signature Bank $153.51 / -1.84 (-1.18%) Reports Q4 book value per… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events SBNY Signature Bank $153.51 / -1.84 (-1.18%) 12/17/20 Signature names Lisa Bond chief corporate social impact officer, Ana Harris CHRO SBNY Signature Bank $153.51 / -1.84 (-1.18%) 01/04/21 Stephens Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens 12/17/20 Seaport Global Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys 12/17/20 Seaport Global Signature Bank initiated with a Buy at Seaport Global 12/16/20 Raymond James Signature Bank price target raised to $153 from $138 at Raymond James SBNY Signature Bank $153.51 / -1.84 (-1.18%) 10/20/20 Signature Bank reports Q3 EPS 2.62, consensus $2.76 07/21/20 Signature Bank reports Q2 EPS $2.21, consensus $2.24 SBNY Signature Bank $153.51 / -1.84 (-1.18%) 01/12/21 Deutsche Bank won't do future business with Trump, NY Times reports 10:00 Today Signature Bank - SBNY 01/27/21 Signature Bank
Recommendations	Halozyme price target raised to $59 from $46 at Benchmark » 05:06 01/21/21 01/21 05:06 01/21/21 05:06 HALO Halozyme $47.73 / -0.57 (-1.18%) Benchmark analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HALO Halozyme $47.73 / -0.57 (-1.18%) 01/15/21 Halozyme says Janssen receives FDA approval of Darzalex Faspro 12/23/20 Halozyme announces EC approval of Roche fixed-dose combination with Enhanze 12/07/20 Halozyme's Kelly sells 35,086 common shares 12/02/20 Halozyme's Kelley sells 31,792 common shares HALO Halozyme $47.73 / -0.57 (-1.18%) 01/14/21 Piper Sandler Halozyme price target raised to $50 from $42 at Piper Sandler 01/11/21 Benchmark Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 12/17/20 Berenberg Halozyme initiated with a Buy at Berenberg HALO Halozyme $47.73 / -0.57 (-1.18%) 01/11/21 Halozyme sees FY21 GAAP EPS $1.40-$1.55, consensus $1.79 11/23/20 Halozyme raises FY20 EPS view to 90c-95c from 80c-85c, consensus 86c 11/02/20 Halozyme raises FY20 GAAP EPS view to 80c-85c from 60c-75 11/02/20 Halozyme reports Q1 EPS 25c, consensus 19c HALO Halozyme $47.73 / -0.57 (-1.18%) 11/05/20 Fly Intel: After-Hours Movers 11/02/20 Fly Intel: After-Hours Movers 08/10/20 Fly Intel: After-Hours Movers 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference
Upgrade	Sanderson Farms upgraded to Outperform from Market Perform at BMO Capital » 05:04 01/21/21 01/21 05:04 01/21/21 05:04 SAFM Sanderson Farms $134.50 / +5.5 (+4.26%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events SAFM Sanderson Farms $134.50 / +5.5 (+4.26%) 12/06/20 Fly Intel: Top five weekend stock stories 10/29/20 Sanderson Farms up 6% to $129.60 after announcing rejection of takeover bid 10/29/20 Sanderson says unsolicited, 'opportunistic' $142 per share bid rejected 10/29/20 Sanderson Farms says no proposal received from Tyson Foods and Durational SAFM Sanderson Farms $134.50 / +5.5 (+4.26%) 12/18/20 Goldman Sachs Sanderson Farms downgraded to Neutral from Buy at Goldman Sachs 11/09/20 Stephens Stephens says McDonald's new sandwich launch positive for chicken producers 10/19/20 BMO Capital Sanderson Farms price target lowered to $132 from $150 at BMO Capital 09/10/20 Fly Intel: Top five analyst upgrades SAFM Sanderson Farms $134.50 / +5.5 (+4.26%) 12/17/20 Sanderson Farms reports Q4 EPS $1.26, consensus 12c 12/16/20 Notable companies reporting before tomorrow's open 12/16/20 Notable companies reporting before tomorrow's open 08/27/20 Sanderson Farms reports Q3 EPS $1.48, consensus 95c SAFM Sanderson Farms $134.50 / +5.5 (+4.26%) 12/06/20 Chick-fil-A sues Tyson, others for poultry price-fixing, Bloomberg says 11/05/20 Sanderson Farms not in deal talks after rejecting takeover bid, CTFN says 11/05/20 CTFN publishes report on Sanderson Farms' deal potential 09/04/20 Bob Evans sues Tyson, others for inflating chicken prices, Bloomberg reports SAFM Sanderson Farms $134.50 / +5.5 (+4.26%) 10/29/20 Fly Intel: Wall Street's top stories for Thursday 08/05/20 Apple downgrade, Disney upgrade among today's top calls on Wall Street 02/18/21 Sanderson Farms Inc.

Hot Stocks	Elbit Systems subsidiary awarded $137M contract by UK Ministry of Defence » 05:02 01/21/21 01/21 05:02 01/21/21 05:02 ESLT Elbit Systems $137.40 / +0.52 (+0.38%) Elbit Systems announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research ESLT Elbit Systems $137.40 / +0.52 (+0.38%) 01/13/21 Elbit Systems awarded contract to supply Seagull USVs 01/11/21 Elbit Systems subsidiary awarded $166M UK MOD contract 01/06/21 Elbit Systems awarded $24M Dutch MOD contract 01/05/21 Elbit Systems to establish Flight Training Center for Hellenic Air Force ESLT Elbit Systems $137.40 / +0.52 (+0.38%) 11/18/20 Jefferies Elbit Systems downgraded to Hold on defense slowdown at Jefferies 11/18/20 Jefferies Elbit Systems downgraded to Hold from Buy at Jefferies 01/27/20 Jefferies Jefferies starts Elbit Systems at Buy with $185 price target 01/27/20 Jefferies Elbit Systems initiated with a Buy at Jefferies
Initiation	Cascades initiated with an Outperform at BMO Capital » 05:02 01/21/21 01/21 05:02 01/21/21 05:02 CADNF Cascades $0.00 / + (+0.00%) BMO Capital analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CADNF Cascades $0.00 / + (+0.00%) 01/08/21 RBC Capital Cascades upgraded to Outperform from Sector Perform at RBC Capital 12/16/20 National Bank Cascades price target lowered to C$21 from C$22 at National Bank 11/13/20 CIBC Cascades price target lowered to C$20 from C$22 at CIBC 11/13/20 National Bank Cascades price target lowered to C$22 from C$22.50 at National Bank
Initiation	Clearwater Paper initiated with an Outperform at BMO Capital » 05:00 01/21/21 01/21 05:00 01/21/21 05:00 CLW Clearwater Paper $40.62 / +0.28 (+0.69%) BMO Capital analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options CLW Clearwater Paper $40.62 / +0.28 (+0.69%) 11/04/20 Clearwater Paper falls -10.8% 08/31/20 Orion Engineered CAO Andre Isfort to depart, Bob Hrivnak to succeed CLW Clearwater Paper $40.62 / +0.28 (+0.69%) 05/07/20 RBC Capital Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital 05/06/20 RBC Capital Clearwater Paper upgraded to Outperform at RBC Capital on 'clear tailwinds' 05/06/20 RBC Capital Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital CLW Clearwater Paper $40.62 / +0.28 (+0.69%) 12/21/20 Clearwater Paper raises Q4 adj. EBITDA view to $71M-$76M from $52M-$62M 11/03/20 Clearwater Paper sees Q4 adj. EBITDA $52M-$62M vs. $20.2M last year 11/03/20 Clearwater Paper sees tissue product demand softening in Q4 11/03/20 Clearwater Paper reports Q3 EPS $1.28, consensus $1.38 CLW Clearwater Paper $40.62 / +0.28 (+0.69%) 11/03/20 Fly Intel: After-Hours Movers CLW Clearwater Paper $40.62 / +0.28 (+0.69%) 11/03/20 ClearWater Paper options imply 11.8% move in share price post-earnings
Initiation	Molina Healthcare initiated with a Neutral at Goldman Sachs » 04:58 01/21/21 01/21 04:58 01/21/21 04:58 MOH Molina Healthcare $222.67 / +3.38 (+1.54%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events MOH Molina Healthcare $222.67 / +3.38 (+1.54%) 01/04/21 CVS Health up 1% after Amazon-Berkshire-JPMorgan JV said to disband 11/19/20 Molina Healthcare to begin CFO transition with retirement of Tom Tran in 2021 09/29/20 Molina Healthcare to acquire Affinity Health Plan for $380M MOH Molina Healthcare $222.67 / +3.38 (+1.54%) 01/05/21 Truist Molina Healthcare price target raised to $260 from $240 at Truist 12/22/20 JPMorgan Latest Georgia polling favors Republicans, says JPMorgan 11/11/20 Piper Sandler Molina Healthcare price target raised to $266 from $213 at Piper Sandler 10/13/20 Truist Truist raises price targets on select Healthcare Services names MOH Molina Healthcare $222.67 / +3.38 (+1.54%) 10/28/20 Molina Healthcare says FY21 improved with Affinity deal 10/28/20 Molina Healthcare raises FY20 revenue view to roughly $19.6B from $18.8B 10/28/20 Molina Healthcare reports Q3 adjusted EPS $3.36, consensus $2.16 10/28/20 Notable companies reporting after market close MOH Molina Healthcare $222.67 / +3.38 (+1.54%) 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says MOH Molina Healthcare $222.67 / +3.38 (+1.54%) 11/14/20 Week in review: How Trump's policies moved stocks 07/30/20 Fly Intel: After-Hours Movers 02/11/21 Molina Healthcare - MOH
Initiation	Centene initiated with a Neutral at Goldman Sachs » 04:57 01/21/21 01/21 04:57 01/21/21 04:57 CNC Centene $62.42 / -0.385 (-0.61%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CNC Centene $62.42 / -0.385 (-0.61%) 01/04/21 CVS Health up 1% after Amazon-Berkshire-JPMorgan JV said to disband 01/04/21 Centene to acquire Magellan Health for $95.00 per share in cash 12/30/20 Centene completes acquisition of PANTHERx Rare Pharmacy 12/18/20 Deerfield Healthcare Technology Acquisitions agrees to merger with CareMax CNC Centene $62.42 / -0.385 (-0.61%) 01/15/21 Fly Intel: Top five analyst downgrades 01/15/21 Jefferies Magellan Health downgraded to Hold after takeover agreement at Jefferies 01/15/21 Jefferies Jefferies downgrades Centene to Hold, sees Dem win benefits pulled forward 01/15/21 Jefferies Anthem upgraded to Buy on more constructive commercial outlook at Jefferies CNC Centene $62.42 / -0.385 (-0.61%) 12/18/20 Centene backs FY20 adjusted EPS view $4.90-$5.06, consensus $4.99 12/18/20 Centene sees FY21 adjusted EPS $5.00-$5.30, consensus $5.44 10/27/20 Centene raises FY20 adj. EPS view to $4.90-$5.06 from $4.76-$4.96 10/27/20 Centene reports Q3 adj. EPS $1.26, consensus 96c CNC Centene $62.42 / -0.385 (-0.61%) 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says CNC Centene $62.42 / -0.385 (-0.61%) 01/04/21 Fly Intel: Wall Street's top stories for Monday 01/04/21 Fly Intel: Wall Street's top stories at midday 01/04/21 Fly Intel: Pre-market Movers 11/14/20 Week in review: How Trump's policies moved stocks 02/09/21 Centene - CNC CNC Centene $62.42 / -0.385 (-0.61%) 10/13/20 Centene put volume heavy and directionally bearish 09/21/20 Centene put volume heavy and directionally bearish 09/01/20 Centene put volume heavy and directionally bearish 08/31/20 Centene call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

DFS
Today at 08:00

Discover - DFS Conference Calls
WNS
Today at 08:00

WNS Holdings - WNS Conference Calls
TAL
Today at 08:00

TAL Education - TAL Conference Calls
STL
Today at 08:00

Sterling Bancorp - STL Conference Calls
TFC
Today at 08:00

Truist Financial - TFC Conference Calls
SI
Today at 08:00

Silvergate Capital - SI Conference Calls
BEDU
Today at 08:00

Bright Scholar - BEDU Conference Calls
CTXS
Today at 08:15

Citrix - CTXS Conference Calls
PLXS
Today at 08:30

Plexus - PLXS Conference Calls
UNP
Today at 08:45

Union Pacific - UNP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $ Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer $8.50-9.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG $5.76 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink $56.93 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum $66.43 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Hexcel price target raised to $45 from $37 at BMO Capital

TODAY'S FREE FLY STORIES

Get Full Fly Access